Production of stable bispecific IgG1 by controlled Fab-arm exchange: Scalability from bench to large-scale manufacturing by application of standard approaches

The manufacturing of bispecific antibodies can be challenging for a variety of reasons. For example, protein expression problems, stability issues, or the use of non-standard approaches for manufacturing can result in poor yield or poor facility fit. In this paper, we demonstrate the use of standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramer, Michael J, van den Bremer, Ewald TJ, van Kampen, Muriel D, Kundu, Amitava, Kopfmann, Peter, Etter, Eric, Stinehelfer, David, Long, Justin, Lannom, Tom, Noordergraaf, Esther H, Gerritsen, Jolanda, Labrijn, Aran F, Schuurman, Janine, van Berkel, Patrick HC, Parren, Paul WHI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896610/
https://www.ncbi.nlm.nih.gov/pubmed/23995617
http://dx.doi.org/10.4161/mabs.26233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896610/
https://www.ncbi.nlm.nih.gov/pubmed/23995617
http://dx.doi.org/10.4161/mabs.26233

Ejemplares similares